Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
'Treat to Target' - Lessons Learnt.
Kurti Z, Vegh Z, Golovics PA, Lakatos PL. Kurti Z, et al. Among authors: vegh z. Dig Dis. 2016;34(1-2):147-52. doi: 10.1159/000443131. Epub 2016 Mar 16. Dig Dis. 2016. PMID: 26981855 Review.
Can we Predict Disease Course with Clinical Factors?
Vegh Z, Kurti Z, Golovics PA, Lakatos PL. Vegh Z, et al. Curr Drug Targets. 2018;19(7):791-797. doi: 10.2174/1389450118666170329095123. Curr Drug Targets. 2018. PMID: 28378692 Review.
Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort.
Gonczi L, Gecse KB, Vegh Z, Kurti Z, Rutka M, Farkas K, Golovics PA, Lovasz BD, Banai J, Bene L, Gasztonyi B, Kristof T, Lakatos L, Miheller P, Nagy F, Palatka K, Papp M, Patai A, Salamon A, Szamosi T, Szepes Z, Toth GT, Vincze A, Szalay B, Molnar T, Lakatos PL. Gonczi L, et al. Among authors: vegh z. Inflamm Bowel Dis. 2017 Nov;23(11):1908-1915. doi: 10.1097/MIB.0000000000001237. Inflamm Bowel Dis. 2017. PMID: 28922253
Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies.
Gonczi L, Kurti Z, Golovics PA, Lovasz BD, Menyhart O, Seres A, Sumegi LD, Gal A, Ilias A, Janos P, Gecse KB, Bessisow T, Afif W, Bitton A, Vegh Z, Lakatos PL. Gonczi L, et al. Among authors: vegh z. Dig Liver Dis. 2018 Jan;50(1):37-41. doi: 10.1016/j.dld.2017.09.137. Epub 2017 Oct 9. Dig Liver Dis. 2018. PMID: 29107471
[Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary].
Kiss LS, Szamosi T, Molnár T, Miheller P, Lakatos L, Vincze A, Palatka K, Bartha Z, Gasztonyi B, Salamon A, Horváth G, Tóth GT, Farkas K, Banai J, Tulassay Z, Nagy F, Szenes M, Veres G, Lovász BD, Végh Z, Golovics PA, Szathmári M, Papp M, Lakatos PL. Kiss LS, et al. Among authors: vegh z. Orv Hetil. 2011 Sep 4;152(36):1433-42. doi: 10.1556/OH.2011.29200. Orv Hetil. 2011. PMID: 21865144 Hungarian.
98 results